Floatz logo

L-2-AMINO-PENTANEDIOIC ACID

HIV Infections

Small moleculePhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

62 Active assets in the HIV Infections cohort.

Asset / SponsorPhaseRating
Raltegravir
Helsinki University Central Hospital
Phase 4A
Efavirenz
The Cleveland Clinic
Phase 4BBB
ZIDOVUDINE
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase 4BBB
Ganciclovir
Phase 4BBB
Dolutegravir
Instituto Mexicano del Seguro Social
Phase 4BBB

View all 50 →

Same molecule, other indications

L-2-AMINO-PENTANEDIOIC ACID is also rated in:

toxic encephalopathyDormant
BB
Indicative ·
64 / 100
View asset →
peripheral neuropathyDormant
B
Indicative ·
62 / 100
View asset →
kidney cancerDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →